Selected research
Industry Growth & Trends
Global Non-animal Capsule Industry Growth and Trends Forecast to 2032
Market perspective
The global Non-animal Capsule market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Non-animal Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Non-animal Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Non-animal Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Non-animal Capsule include Qingdao Capsule, Lonza (Capsugel), Shanxi GS Capsule, Sunil Healthcare, Suheung Capsule, SIRIO, Robinson Pharma, Qualicaps and Procaps Laboratorios, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Non-animal Capsule market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Non-animal Capsule market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-animal Capsule market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-animal Capsule.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Non-animal Capsule market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Non-animal Capsule Market by Company
Qingdao Capsule
Lonza (Capsugel)
Shanxi GS Capsule
Sunil Healthcare
Suheung Capsule
SIRIO
Robinson Pharma
Qualicaps
Procaps Laboratorios
Lefan Capsule
Eurocaps
Er-kang
Catalent
Captek
CapsCanada
Best Formulations
Bahrain Pharma
Aenova
ACG Associated Capsules
Non-animal Capsule Segment by Type
HPMC
Starch
Plant Polysaccharides
Others
Non-animal Capsule Segment by Application
Pharmaceutical
Health Supplements
Others
Non-animal Capsule Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-animal Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-animal Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-animal Capsule.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-animal Capsule manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Non-animal Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- HPMC
- Starch
- Plant Polysaccharides
- Others
Applications
- Pharmaceutical
- Health Supplements
- Others
Companies covered
- Qingdao Capsule
- Lonza (Capsugel)
- Shanxi GS Capsule
- Sunil Healthcare
- Suheung Capsule
- SIRIO
- Robinson Pharma
- Qualicaps
- Procaps Laboratorios
- Lefan Capsule
- Eurocaps
- Er-kang
- Catalent
- Captek
- CapsCanada
- Best Formulations
- Bahrain Pharma
- Aenova
- ACG Associated Capsules
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Non-animal Capsule Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Non-animal Capsule Sales Estimates and Forecasts (2021-2032)
- 1.3 Non-animal Capsule Market by Type
- 1.3.1 HPMC
- 1.3.2 Starch
- 1.3.3 Plant Polysaccharides
- 1.3.4 Others
- 1.4 Global Non-animal Capsule Market Size by Type
- 1.4.1 Global Non-animal Capsule Market Size Overview by Type (2021-2032)
- 1.4.2 Global Non-animal Capsule Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Non-animal Capsule Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Non-animal Capsule Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Non-animal Capsule Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Non-animal Capsule Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Non-animal Capsule Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Non-animal Capsule Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Non-animal Capsule Industry Trends
- 2.2 Non-animal Capsule Industry Drivers
- 2.3 Non-animal Capsule Industry Opportunities and Challenges
- 2.4 Non-animal Capsule Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Non-animal Capsule Revenue (2021-2026)
- 3.2 Global Top Players by Non-animal Capsule Sales (2021-2026)
- 3.3 Global Top Players by Non-animal Capsule Price (2021-2026)
- 3.4 Global Non-animal Capsule Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Non-animal Capsule Major Company Production Sites & Headquarters
- 3.6 Global Non-animal Capsule Company, Product Type & Application
- 3.7 Global Non-animal Capsule Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Non-animal Capsule Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Non-animal Capsule Players Market Share by Revenue in 2025
- 3.8.3 2025 Non-animal Capsule Tier 1, Tier 2, and Tier 3
4 Non-animal Capsule Regional Status and Outlook
- 4.1 Global Non-animal Capsule Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Non-animal Capsule Historic Market Size by Region
- 4.2.1 Global Non-animal Capsule Sales in Volume by Region (2021-2026)
- 4.2.2 Global Non-animal Capsule Sales in Value by Region (2021-2026)
- 4.2.3 Global Non-animal Capsule Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Non-animal Capsule Forecasted Market Size by Region
- 4.3.1 Global Non-animal Capsule Sales in Volume by Region (2027-2032)
- 4.3.2 Global Non-animal Capsule Sales in Value by Region (2027-2032)
- 4.3.3 Global Non-animal Capsule Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Non-animal Capsule by Application
- 5.1 Non-animal Capsule Market by Application
- 5.1.1 Pharmaceutical
- 5.1.2 Health Supplements
- 5.1.3 Others
- 5.2 Global Non-animal Capsule Market Size by Application
- 5.2.1 Global Non-animal Capsule Market Size Overview by Application (2021-2032)
- 5.2.2 Global Non-animal Capsule Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Non-animal Capsule Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Non-animal Capsule Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Non-animal Capsule Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Non-animal Capsule Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Non-animal Capsule Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Non-animal Capsule Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Qingdao Capsule
- 6.1.1 Qingdao Capsule Company Information
- 6.1.2 Qingdao Capsule Business Overview
- 6.1.3 Qingdao Capsule Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Qingdao Capsule Non-animal Capsule Product Portfolio
- 6.1.5 Qingdao Capsule Recent Developments
- 6.2 Lonza (Capsugel)
- 6.2.1 Lonza (Capsugel) Company Information
- 6.2.2 Lonza (Capsugel) Business Overview
- 6.2.3 Lonza (Capsugel) Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Lonza (Capsugel) Non-animal Capsule Product Portfolio
- 6.2.5 Lonza (Capsugel) Recent Developments
- 6.3 Shanxi GS Capsule
- 6.3.1 Shanxi GS Capsule Company Information
- 6.3.2 Shanxi GS Capsule Business Overview
- 6.3.3 Shanxi GS Capsule Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Shanxi GS Capsule Non-animal Capsule Product Portfolio
- 6.3.5 Shanxi GS Capsule Recent Developments
- 6.4 Sunil Healthcare
- 6.4.1 Sunil Healthcare Company Information
- 6.4.2 Sunil Healthcare Business Overview
- 6.4.3 Sunil Healthcare Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sunil Healthcare Non-animal Capsule Product Portfolio
- 6.4.5 Sunil Healthcare Recent Developments
- 6.5 Suheung Capsule
- 6.5.1 Suheung Capsule Company Information
- 6.5.2 Suheung Capsule Business Overview
- 6.5.3 Suheung Capsule Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Suheung Capsule Non-animal Capsule Product Portfolio
- 6.5.5 Suheung Capsule Recent Developments
- 6.6 SIRIO
- 6.6.1 SIRIO Company Information
- 6.6.2 SIRIO Business Overview
- 6.6.3 SIRIO Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 SIRIO Non-animal Capsule Product Portfolio
- 6.6.5 SIRIO Recent Developments
- 6.7 Robinson Pharma
- 6.7.1 Robinson Pharma Company Information
- 6.7.2 Robinson Pharma Business Overview
- 6.7.3 Robinson Pharma Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Robinson Pharma Non-animal Capsule Product Portfolio
- 6.7.5 Robinson Pharma Recent Developments
- 6.8 Qualicaps
- 6.8.1 Qualicaps Company Information
- 6.8.2 Qualicaps Business Overview
- 6.8.3 Qualicaps Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Qualicaps Non-animal Capsule Product Portfolio
- 6.8.5 Qualicaps Recent Developments
- 6.9 Procaps Laboratorios
- 6.9.1 Procaps Laboratorios Company Information
- 6.9.2 Procaps Laboratorios Business Overview
- 6.9.3 Procaps Laboratorios Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Procaps Laboratorios Non-animal Capsule Product Portfolio
- 6.9.5 Procaps Laboratorios Recent Developments
- 6.10 Lefan Capsule
- 6.10.1 Lefan Capsule Company Information
- 6.10.2 Lefan Capsule Business Overview
- 6.10.3 Lefan Capsule Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Lefan Capsule Non-animal Capsule Product Portfolio
- 6.10.5 Lefan Capsule Recent Developments
- 6.11 Eurocaps
- 6.11.1 Eurocaps Company Information
- 6.11.2 Eurocaps Business Overview
- 6.11.3 Eurocaps Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Eurocaps Non-animal Capsule Product Portfolio
- 6.11.5 Eurocaps Recent Developments
- 6.12 Er-kang
- 6.12.1 Er-kang Company Information
- 6.12.2 Er-kang Business Overview
- 6.12.3 Er-kang Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Er-kang Non-animal Capsule Product Portfolio
- 6.12.5 Er-kang Recent Developments
- 6.13 Catalent
- 6.13.1 Catalent Company Information
- 6.13.2 Catalent Business Overview
- 6.13.3 Catalent Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Catalent Non-animal Capsule Product Portfolio
- 6.13.5 Catalent Recent Developments
- 6.14 Captek
- 6.14.1 Captek Company Information
- 6.14.2 Captek Business Overview
- 6.14.3 Captek Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Captek Non-animal Capsule Product Portfolio
- 6.14.5 Captek Recent Developments
- 6.15 CapsCanada
- 6.15.1 CapsCanada Company Information
- 6.15.2 CapsCanada Business Overview
- 6.15.3 CapsCanada Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 CapsCanada Non-animal Capsule Product Portfolio
- 6.15.5 CapsCanada Recent Developments
- 6.16 Best Formulations
- 6.16.1 Best Formulations Company Information
- 6.16.2 Best Formulations Business Overview
- 6.16.3 Best Formulations Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Best Formulations Non-animal Capsule Product Portfolio
- 6.16.5 Best Formulations Recent Developments
- 6.17 Bahrain Pharma
- 6.17.1 Bahrain Pharma Company Information
- 6.17.2 Bahrain Pharma Business Overview
- 6.17.3 Bahrain Pharma Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Bahrain Pharma Non-animal Capsule Product Portfolio
- 6.17.5 Bahrain Pharma Recent Developments
- 6.18 Aenova
- 6.18.1 Aenova Company Information
- 6.18.2 Aenova Business Overview
- 6.18.3 Aenova Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Aenova Non-animal Capsule Product Portfolio
- 6.18.5 Aenova Recent Developments
- 6.19 ACG Associated Capsules
- 6.19.1 ACG Associated Capsules Company Information
- 6.19.2 ACG Associated Capsules Business Overview
- 6.19.3 ACG Associated Capsules Non-animal Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 ACG Associated Capsules Non-animal Capsule Product Portfolio
- 6.19.5 ACG Associated Capsules Recent Developments
7 North America by Country
- 7.1 North America Non-animal Capsule Sales by Country
- 7.1.1 North America Non-animal Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Non-animal Capsule Sales by Country (2021-2026)
- 7.1.3 North America Non-animal Capsule Sales Forecast by Country (2027-2032)
- 7.2 North America Non-animal Capsule Market Size by Country
- 7.2.1 North America Non-animal Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Non-animal Capsule Market Size by Country (2021-2026)
- 7.2.3 North America Non-animal Capsule Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Non-animal Capsule Sales by Country
- 8.1.1 Europe Non-animal Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Non-animal Capsule Sales by Country (2021-2026)
- 8.1.3 Europe Non-animal Capsule Sales Forecast by Country (2027-2032)
- 8.2 Europe Non-animal Capsule Market Size by Country
- 8.2.1 Europe Non-animal Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Non-animal Capsule Market Size by Country (2021-2026)
- 8.2.3 Europe Non-animal Capsule Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Non-animal Capsule Sales by Country
- 9.1.1 Asia-Pacific Non-animal Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Non-animal Capsule Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Non-animal Capsule Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Non-animal Capsule Market Size by Country
- 9.2.1 Asia-Pacific Non-animal Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Non-animal Capsule Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Non-animal Capsule Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Non-animal Capsule Sales by Country
- 10.1.1 South America Non-animal Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Non-animal Capsule Sales by Country (2021-2026)
- 10.1.3 South America Non-animal Capsule Sales Forecast by Country (2027-2032)
- 10.2 South America Non-animal Capsule Market Size by Country
- 10.2.1 South America Non-animal Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Non-animal Capsule Market Size by Country (2021-2026)
- 10.2.3 South America Non-animal Capsule Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Non-animal Capsule Sales by Country
- 11.1.1 Middle East and Africa Non-animal Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Non-animal Capsule Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Non-animal Capsule Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Non-animal Capsule Market Size by Country
- 11.2.1 Middle East and Africa Non-animal Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Non-animal Capsule Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Non-animal Capsule Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Non-animal Capsule Value Chain Analysis
- 12.1.1 Non-animal Capsule Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Non-animal Capsule Production Mode & Process
- 12.2 Non-animal Capsule Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Non-animal Capsule Distributors
- 12.2.3 Non-animal Capsule Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst